impact proteam inhibitor antiretrovir treatment acquire immunodefici syndrome survive san francisco california sandra k schwartz ling chin hu eric vittinghoff mitchell h katz depart public health ca epidemiology biostatist universe abstract top introduce mater method result discus refer author ass tempo trend aid person diagnose opportunity ill include case deficit predictor value met median month decrease mortal assoc use therapy without rel hazard rh config inter ci agent increase found age year init homosexual inject drug user treatment particularly strongly predict improv hiv abbrev human virus sever recent clinic trial cohort studi clinical studi shown combine regimen decrease morbid infect howe effect genre popup demons may effect particle enroll include difficult adhere lang number pill require frequent dose side effect interact substance homeless mental ill like greater difficult comply underrepres multicent time death among hivinfect seen calendar avail gay bisexual men thu limit bail genre two perform special center known longer care hivexperienc physician therefore undertook populations medic report compare demography risk subgroup january decent juli case primarily percent active survey conduct fail largest number remained passive review local certify retrospect review report depart value report complete percentage consist previous value highly revid outside exclude sample incomplete data inform subset aiding ill cd test start date prophylact obtain prospect laboratory record medic chart weekly annual match nation index match death occur analysis call diagnosis allcaus autopsy date could determine meet earlier deficit use first aidsdefin die censor last followup which kaplanmei product limit method call roport survive value examine four cohort period select distinguish zidovudin didanosin zalcitabin became wide examine limit since place abl either person use cox roport hazard model classify one five category init prior inhibitor began receive n spear category subject sequence mani three eg pl character sum personid spent model classis implement timedepend variable reclassified avoid fix cover metres history induce select bia regard survivor survive chance adhere withdraw reclassified discontinue assume potent cultivar also factor age gender raceethn group count within present absence primary prophylaxi pneumocysti caring pneumonia mycobacterium album complex supplementary various woman white african american latino inject drug heterosexual india specify group already describe wall chisquar ass differ status test sa software institut inc car north carolina total develop least eightysix eight month unknown figure cum survive respect view larger version window new productlimit est probably year occur exclude develop miss result characters similar cultivar significantly table somewhat work noninject race ethnic higher cell predict receipt reduce ad lower start p effect secondary restrict improv unitary except adjust lower ratio interact term exceed rang india although protect persist attend slightly admit differ stratified demons substantial increase period coincide therapy introduce assoc expand option substantial show drama odd india extend find clinic establish across factor find highlight import address display access example le receive clinician init thought comply prove treat product level efficacy nonetheless demons exclude base receive combine unclear whether undo true display future size compare treat derive benefit size dwarf little early reflect admit lamivudin stavudin double triplecombin india draw maximum lesseffect failure discontinue find observe product mix possible prevent infect measure take account alter patient constitute symptom unable adjust lack kicker elsewhere due increase develop result later stage would decline whose init support theory present older virtual better care improv manga ethnic provost differ regimen compete caps homicide overdose limit contain detail adjust count viral load system influence sever probably underestim registry provide chang staff collect type medic patient actual result underestim sequence monotherapi longterm prognosis poor advance respect provide optimism yet shorter translate necessary determine current hired acknowledge research support cooper agreement ucc disease control prevent atlanta georgia thank mare kay parish unit collect nancy vessel dr susan sheer critic manuscript note reprint request van ness avenue suit email sandyschwarczatdphsfcau var u sandyschwarcz dphsfcau documentgetelementbyideminnerhtml hrefmailto clumeck saquinavir intern phase iii trial saqinavir treat mini program abstract th interact confer antimicrobial chemotherapy toronto ontario canada september actor lb hammer sm squid ke hugh md et al control nucleotide analog indinavir per cubic millet engl j med abstractfre full text stretcher l shear chang rna aidsdeath deter r minor mcfarlan g potent jama pamela fj delayed km morgan ac decline advance michael sh clark kissing letter free desk sg smith holodniy cleaner c hivproteas meta moor rd graham nm affect isimedlin kitahata mm koepsel td demo ra expert sk lc mk complete timely lamp gf hirozawa cohen jb infect di ranch kj rutherford gw echenberg df value office american relay organ la vega nevada washington dc sarah aj hoover influence report mac air immune desc send made hopkins sser state chang acquire merlin mocroft you margin bmj almond charleboi e lang w piety mor v freshman pattern unit state serv re rothenburg woelfel stoneburn syndromeexperi york city blue singh tp gibbon dead spider epidemic harry je short term chang sw mh hernandez sr italic della chiesa vol different accord cdc revid mmwr more mortal wki rep supplement revid system adolesc adult elebi mj survivor example literature ann intern park lp jackson infect clip kuo markowitz sang powder wg preliminary ritonavir treat manner sa carr leonard jm safety pharmacokinet quick rm mellow jw hair kitchen v skinned ariyoshi active lancet celentano hlavov perfreport strathde pale corneliss pga barrier lundgren jd phillip peterson comparison colbert pa laga grime asymptomatic prolong protocol hamilton martin pm simberkoff m versus late symptoms giuliano pezzotti contemporary khan jo richmond dd compare continue said bram di goldman ai later compare hong r oshaughnessi mv qatar antiretrovir heath kv ip b individual follow init chanson kerala jc sex progress darminio consort mining f torment milan stein d acyclovir pay sf neal binder pj poo rm jong jt amsterdam hh more dl noon barrel snow ong el east england kirby poll lafferti hidden people peterson european barton se katlama episode arch lu law valor role hidalgo england bw natur seat gr oddleifson massachusetts season ce cooper da outcome australia whitmoreoverton millet evan bg adult kingdom delay never sl cellar manifest era music present friedman gh salesman video anton sergio rate disease fernando sj wall tl baki psychiatry illicit at alcohol bus broker arabia michel compliance haastrecht hja ameijden etc den hook jar hivposit hive sewn alma cartel kou aidsfre seroposit public april accept august 